Meningiomas
Lancet 363:1535-1543, Whittle,I.R.,et al, 2004
Training Care Givers of Stroke Patients: Randomised Controlled Trial
BMJ 328:1099-1101, Kalra,L.,et al, 2004
Training Care Givers of Stroke Patients: Economic Evaluation
BMJ 328:1102-1104, Patel,A.,et al, 2004
Assessment: Transcranial Doppler Ultrasonography
Neurol 62:1468-1481, Sloan,M.A.,et al, 2004
Ropinirole in Gilles de la Tourette Syndrome
Neurol 62:1626-1627, Anea,M.H.,et al, 2004
Percutaneous Closure of Patent Foramen Ovale Reduces the Frequency of Migraine attacks
Neurol 62:1399-1401, Schwerzmann,M.,et al, 2004
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
Efficacy of Pergolide in Treatment of Restless Legs Syndrome
Neurol 62:1391-1397, Trenkwalder,C.,et al, 2004
Paraneoplastic "Stiff Person Syndrome" with Metastatic Adenocarcinoma and anti-Ri Antibodies
Neurol 62:1402-1404, McCabe,D.J.H.,et al, 2004
Nimodipine for Treatment of Primary Thunderclap Headache
Neurol 62:1414-1416, Lu,S.-R.,et al, 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Plasmapheresis Improves Outcome in Postinfectious Cerebellitis Induced by Epsteiin-Barr Virus
Neurol 62:1443, Schmahmann,J.D., 2004
Treatment of Refractory Neurosarcoidosis with Cladribine
NEJM 350:1798-1799, Tikoo,R.K.,et al, 2004
Fibromuscular Dysplasia
NEJM 350:1862-1871, Slovut,D.P. &Olin,J.W., 2004
Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004
Mechanical Thrombolysis in Acute Ischemic Stroke With Endovascular Photoacoustic Recanalization
Stroke 35:1112-1116, Berlis,A.,et al, 2004
Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004
Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004
Physical Activity and Exercise Recommendations for Stroke Survivors
Stroke 35:1230-1240, Gordon,N.F.,et al, 2004
Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004
Developmental Dyslexia
Lancet 363:1451-60, Demonet,J-F.,et al, 2004
Naturally Acquired West Nile Virus Encephalomyelitis in Transplant Recipients
Arch Neurol 61:1210-1220, Kleinschmidt-DeMasters,B.K.,et al, 2004
Surgical and Hardware Complications of Subthalamic Stimulation
Neurol 63:612-616, Lyons,K.E.,et al, 2004
Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004
Efficacy of Donepezil in Mild Cognitive Impairment
Neurol 63:651-657, Salloway,S.,et al, 2004
Seizure Outcomes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations
Neurol 63:683-687, Schauble,B.,et al, 2004
Efficacy of Mycophenolate Mofetil in Patients with Chronic Immune Demyelinating Polyneuropathy
NEruol 63:715-717, Gorson,K.C.,et al, 2004
Hallucinations During Methylphenidate Therapy
Neurol 63:753-754, Gross-Tsur,V.,et al, 2004
Melatonin, 3 mg, is Effective for Migraine Prevention
Neurol 63:757, Peres,M.F.P.,et al, 2004
HSV-2 Sacral Radiculitis (Elsberg Syndrome)
Neurol 63:758-759, Eberhardt,O.,et al, 2004
Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
Acquired Haemophilia A May be Associated with Clopidogrel
BMJ 329:323, Haj,M.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?"
Stroek 35:2140, Anzola,G.P.,et al, 2004
Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004
Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004
Rabies Transmission From Organ Transplants in the USA
Lancet 364:648-649, Dietzschold,B. &Koprowski,H., 2004
European Study on Intravenous Immunoglobulin in Multiple Sclerosis
Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004
Botulinum Toxin Type A for Treating Voice Tremor
Arch Neurol 61:1416-1420, Adler,C.H.,et al, 2004
Salvage Therapy for Primary CNS Lymphoma with a Combination of Rituximab and Temozolomide
Neurol 63:901-903, Enting,R.H.,et al, 2004
Recent Developments in Bell's Palsy
BMJ 329:553-557, Holland,N.J. & Weiner,G.M., 2004
Monoamine Oxide Type B Inhibitors in Early Parkinson's Disease:Meta-Analysis of 17 Randomised Trials Involving 3525 Patients
BMJ 329:593-596, Ives,N.J.,et al, 2004
Clinicopath Conf, Pernicious Anema with Autoimmune Gastritis and B12 Deficiency
NEJM 351:1333-1341, Case 30-2004, 2004
Bell's Palsy
NEJM 351:1323-1331, Gilden,D.H., 2004
Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004
Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004
Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004
Expanding the Range of Therapies for Acute Ischemic Stroke: The Early Experience of the Regional Stroke Center at Hartford Hospital
Connecticut Medicine 68:419-429, Silvernman,I.E.,et al, 2004
Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004